HomeCompareBKEAY vs JNJ

BKEAY vs JNJ: Dividend Comparison 2026

BKEAY yields 3.74% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKEAY wins by $608.9K in total portfolio value
10 years
BKEAY
BKEAY
● Live price
3.74%
Share price
$1.67
Annual div
$0.06
5Y div CAGR
54.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$639.2K
Annual income
$384,747.07
Full BKEAY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BKEAY vs JNJ

📍 BKEAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKEAYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKEAY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKEAY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKEAY
Annual income on $10K today (after 15% tax)
$317.94/yr
After 10yr DRIP, annual income (after tax)
$327,035.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, BKEAY beats the other by $323,049.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKEAY + JNJ for your $10,000?

BKEAY: 50%JNJ: 50%
100% JNJ50/50100% BKEAY
Portfolio after 10yr
$334.7K
Annual income
$194,718.23/yr
Blended yield
58.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BKEAY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.2
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKEAY buys
0
JNJ buys
0
No recent congressional trades found for BKEAY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKEAYJNJ
Forward yield3.74%2.13%
Annual dividend / share$0.06$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR54.9%28%
Portfolio after 10y$639.2K$30.3K
Annual income after 10y$384,747.07$4,689.40
Total dividends collected$591.6K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: BKEAY vs JNJ ($10,000, DRIP)

YearBKEAY PortfolioBKEAY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,279$579.40$10,592$272.30+$687.00BKEAY
2$13,015$946.09$11,289$357.73+$1.7KBKEAY
3$15,506$1,580.37$12,123$472.89+$3.4KBKEAY
4$19,318$2,725.80$13,141$629.86+$6.2KBKEAY
5$25,586$4,915.93$14,408$846.81+$11.2KBKEAY
6$36,803$9,425.78$16,021$1,151.60+$20.8KBKEAY
7$59,006$19,627.46$18,122$1,588.22+$40.9KBKEAY
8$108,693$45,556.55$20,930$2,228.20+$87.8KBKEAY
9$237,787$121,485.02$24,792$3,191.91+$213.0KBKEAY
10$639,179$384,747.07$30,274$4,689.40+$608.9KBKEAY

BKEAY vs JNJ: Complete Analysis 2026

BKEAYStock

The Bank of East Asia, Limited, together with its subsidiaries, provides various banking and related financial services. Its personal banking services include corporate, individual, savings, current, time deposit, and supreme accounts; and fixed and call deposits, foreign currency deposits, MAS services, and auto-payroll products, as well as safe deposit boxes and remittance services. The company also provides corporate banking services, such as SME loans and financing guarantee schemes; corporate and commercial financing products, including syndicated and construction loans, acquisition and structured financing, working capital financing, share financing and IPO-related loans, and commercial mortgages; trade finance services and expert trade solutions; factoring services; import and export trade finance; guarantee services; eTradeConnect that allows buyers and sellers to connect, transact, share information, and submit applications for financing through a single platform; cash management services; corporate wealth management products; foreign exchange and treasury products; trade settlement and financing services; onshore and offshore loans; and marine cargo, property, trade credit, employee compensation, pet, medical, life, savings, and endowment insurance plans. In addition, it offers private banking services comprising investment advisory services; investment solutions, such as unit trusts, linked deposits, currency trading and management, global equities and bonds investments, structured products, and options and derivatives; portfolio management services; securities and futures broking services; cyber banking, credit cards, and ATM; and various international services. The company operates 150 outlets in Hong Kong, rest of Greater China, Southeast Asia, the United Kingdom, and the United States. The Bank of East Asia, Limited was incorporated in 1918 and is headquartered in Central, Hong Kong.

Full BKEAY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BKEAY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKEAY vs SCHDBKEAY vs JEPIBKEAY vs OBKEAY vs KOBKEAY vs MAINBKEAY vs ABBVBKEAY vs MRKBKEAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.